疫苗包裝市場機會、成長動力、產業趨勢分析及 2024 年至 2032 年預測

2023 年全球疫苗包裝市場價值為18 億美元，預計2024 年至2032 年複合年成長率為10.4%。支持。對先進包裝解決方案的需求不斷成長，以確保疫苗的安全性、有效性以及遵守嚴格的監管標準。具有監控功能的智慧包裝等技術進步進一步提高了疫苗在儲存和分銷過程中的完整性，有助於市場擴張。市場依包裝類型分為初級、二級和三級包裝。

2023年，初級包裝領域佔據主導地位，佔市場佔有率超過52%。這部分對於維持疫苗的穩定性和功效至關重要，因為它包括小瓶、注射器和安瓿，可保護疫苗免受污染，同時保持無菌。這對於需要特定儲存條件的疫苗（例如 mRNA 疫苗）尤其重要。從材料來看，疫苗包裝市場分為玻璃、塑膠、金屬。

塑膠領域預計將經歷強勁成長，預計複合年成長率將超過 11%，到 2032 年將達到 10 億美元以上。它們提供了一種輕質、耐用的玻璃替代品，最大限度地降低了運輸過程中破損的風險。此外，環烯烴聚合物（COP）和共聚物（COC）等先進塑膠材料具有優異的阻隔性能、耐化學性和透明度，使其成為需要冷鏈物流的疫苗的理想選擇。單劑量包裝的趨勢可以減少浪費，也推動了對塑膠的需求，因為它們可以輕鬆地模製成各種形式，如預充式注射器和小瓶。

從地理上看，2023年北美將佔全球疫苗包裝市場的35%以上。合規性，鼓勵包裝解決方案的創新。隨著美國繼續擴大疫苗接種計劃並為未來的公共衛生挑戰做好準備，該公司在開發先進的包裝解決方案以提高疫苗安全性和促進高效分配方面具有巨大潛力。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
  • 影響價值鏈的因素
  • 干擾
  • 未來展望
  • 製造商
  • 經銷商
• 利潤率分析
• 重要新聞和舉措
• 監管環境
• 衝擊力
  • 成長動力
    • 增加全球疫苗接種舉措
    • 對生物製品和複雜疫苗的需求不斷成長
    • 對可靠冷鏈包裝的需求不斷成長
    • 增加政府資金和公共衛生投資
    • 不斷發展的醫療基礎設施
  • 產業陷阱與挑戰
    • 核准流程複雜
    • 初始投資成本高
• 成長潛力分析
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司市佔率分析
• 競爭定位矩陣
• 戰略展望矩陣

第 5 章：市場估計與預測：依產品分類，2021-2032 年

• 主要趨勢
• 小瓶
• 預充式注射器
• 瓶蓋
• 安瓿
• 絕緣盒
• 其他

第 6 章：市場估計與預測：按類型，2021-2032 年

• 主要趨勢
• 初級包裝
• 二次包裝
• 三級包裝

第 7 章：市場估計與預測：按材料分類，2021-2032 年

• 主要趨勢
• 玻璃
• 塑膠
• 金屬

第 8 章：市場估計與預測：按最終用途，2021-2032 年

• 主要趨勢
• 疫苗生產商
• 醫療保健提供者
  • 醫院
  • 診所
  • 疫苗接種中心
• 研究機構
• 其他

第 9 章：市場估計與預測：按地區，2021-2032 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 俄羅斯
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲
• 拉丁美洲
  • 巴西
  • 墨西哥
• MEA
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 10 章：公司簡介

• Amcor
• Aptar Group
• Aseptic
• Becton Dickinson
• Blowkings
• Corning
• CSafe
• DWK Life Sciences
• Fengchen Group
• Gerresheimer
• Nipro
• Romaco Group
• Schott
• Sealed Air
• SGD Pharma
• Shandong Province Medicinal Glass
• Stevanato Group
• UFP Technologies
• West Pharmaceutical Services

The Global Vaccine Packaging Market, valued at USD 1.8 billion in 2023, is expected to grow at a CAGR of 10.4% from 2024 to 2032. This growth is driven by increased global vaccination efforts, which are supported by governments and health organizations worldwide. The demand for advanced packaging solutions that ensure the safety, efficacy, and compliance of vaccines with stringent regulatory standards is rising. Technological advancements, such as smart packaging with monitoring capabilities, are further enhancing vaccine integrity during storage and distribution, contributing to market expansion. The market is segmented based on packaging type into primary, secondary, and tertiary packaging.

In 2023, the primary packaging segment held a dominant share, accounting for over 52% of the market. This segment is essential for maintaining vaccine stability and efficacy, as it includes vials, syringes, and ampoules that protect vaccines from contamination while preserving sterility. This is especially important for vaccines that require specific storage conditions, such as mRNA vaccines. In terms of materials, the vaccine packaging market is divided into glass, plastics, and metals.

The plastics segment is expected to experience robust growth, with a projected CAGR of over 11%, reaching more than USD 1 billion by 2032. Plastics are gaining traction in vaccine packaging due to their versatility and cost-effectiveness. They offer a lightweight, durable alternative to glass, minimizing the risk of breakage during transportation. Additionally, advanced plastic materials like cyclic olefin polymers (COP) and copolymers (COC) provide excellent barrier properties, chemical resistance, and transparency, making them ideal for vaccines requiring cold chain logistics. The trend towards single-dose packaging, which reduces waste, is also driving the demand for plastics, as they can be easily molded into various forms like prefilled syringes and vials.

Geographically, North America accounted for over 35% of the global vaccine packaging market in 2023. The U.S. market plays a crucial role in this growth due to its robust healthcare system and strict regulatory framework, particularly FDA compliance, which encourages innovation in packaging solutions. As the U.S. continues to expand its vaccination programs and prepares for future public health challenges, there is significant potential for companies to develop advanced packaging solutions that enhance vaccine safety and facilitate efficient distribution.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Forecast calculations
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry synopsis, 2021-2032

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factor affecting the value chain
  • 3.1.2 Disruptions
  • 3.1.3 Future outlook
  • 3.1.4 Manufacturers
  • 3.1.5 Distributors
• 3.2 Profit margin analysis
• 3.3 Key news & initiatives
• 3.4 Regulatory landscape
• 3.5 Impact forces
  • 3.5.1 Growth drivers
    • 3.5.1.1 Increasing global vaccination initiatives
    • 3.5.1.2 Rising demand for biologics and complex vaccines
    • 3.5.1.3 Growing demand for reliable cold chain packaging
    • 3.5.1.4 Increased government funding and public health investments
    • 3.5.1.5 Growing healthcare infrastructure
  • 3.5.2 Industry pitfalls & challenges
    • 3.5.2.1 Complex approval processes
    • 3.5.2.2 High initial investment costs
• 3.6 Growth potential analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Product, 2021-2032 (USD Million)

• 5.1 Key trends
• 5.2 Vials
• 5.3 Prefillable syringes
• 5.4 Vial closures
• 5.5 Ampoules
• 5.6 Insulated boxes
• 5.7 Others

Chapter 6 Market Estimates & Forecast, By Type, 2021-2032 (USD Million)

• 6.1 Key trends
• 6.2 Primary packaging
• 6.3 Secondary packaging
• 6.4 Tertiary packaging

Chapter 7 Market Estimates & Forecast, By Material, 2021-2032 (USD Million)

• 7.1 Key trends
• 7.2 Glass
• 7.3 Plastics
• 7.4 Metals

Chapter 8 Market Estimates & Forecast, By End Use, 2021-2032 (USD Million)

• 8.1 Key trends
• 8.2 Vaccine manufacturers
• 8.3 Healthcare providers
  • 8.3.1 Hospitals
  • 8.3.2 Clinics
  • 8.3.3 Vaccination centers
• 8.4 Research institutions
• 8.5 Others

Chapter 9 Market Estimates & Forecast, By Region, 2021-2032 (USD Million)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 UK
  • 9.3.2 Germany
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Russia
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 South Korea
  • 9.4.5 Australia
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
• 9.6 MEA
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Amcor
• 10.2 Aptar Group
• 10.3 Aseptic
• 10.4 Becton Dickinson
• 10.5 Blowkings
• 10.6 Corning
• 10.7 CSafe
• 10.8 DWK Life Sciences
• 10.9 Fengchen Group
• 10.10 Gerresheimer
• 10.11 Nipro
• 10.12 Romaco Group
• 10.13 Schott
• 10.14 Sealed Air
• 10.15 SGD Pharma
• 10.16 Shandong Province Medicinal Glass
• 10.17 Stevanato Group
• 10.18 UFP Technologies
• 10.19 West Pharmaceutical Services